This annual report summarizes Henry Schein's performance in 2007. Some key points:
- Net sales reached a record $5.9 billion, a 17.3% increase over 2006. Income from continuing operations was $235 million, a 28.6% increase.
- All four business groups - Dental, Medical, International, and Technology - posted double-digit sales gains. The Dental group had sales of $2.46 billion.
- The company grew through acquisitions including Becker-Parkin Dental Supply and W&J Dunlop Ltd (animal health in the UK).
- Henry Schein was named one of America's Most Admired Companies by Fortune and
The document summarizes Oshkosh Corporation's earnings conference call for the second quarter of fiscal year 2008. Key highlights include sales increasing 6.7% to $1.8 billion and operating income rising 24.8% to $168.2 million. EPS grew 42.6% to $0.97. While access equipment and defense saw strong demand, commercial and fire & emergency faced challenging market conditions. The company maintained its fiscal year 2008 EPS estimate range of $4.15 to $4.35.
- Cummins has doubled revenue over the past 5 years and achieved the highest 3-year period of net earnings as a percent of sales in over 40 years.
- The company has diversified globally and by end markets to reduce cyclicality, aggressively pursued low cost leadership, and built greater earnings stability.
- Cummins is investing in new engine platforms and technologies to capitalize on growth opportunities from evolving global emission standards.
Yahoo's Q1 2008 financial highlights presentation notes that the document discusses forward-looking statements about Yahoo's expected financial performance and strategic plans that are subject to risks and uncertainties, actual results may differ materially from predictions, and reported results should not be considered indicators of future performance. Potential risks include the results of Yahoo's strategic initiatives, competition, reductions in customer spending, demand for premium services, acceptance of new products and services, risks related to joint ventures and acquisitions, and risks related to international operations.
Robert G. Bohn, Chairman, President and CEO of Oshkosh Truck Corporation, discussed the company's strong third quarter fiscal year 2006 results and provided an outlook for fiscal years 2006 and 2007. Some highlights included record sales and operating income for Q3 2006. The company also announced two acquisitions, AK Specialty Vehicles and Iowa Mold Tooling, expected to be accretive to earnings in fiscal 2007. For fiscal 2006, Oshkosh estimates sales growth of 14.9-16.6% and EPS growth of 24-26%. Fiscal 2007 estimates include sales of $3.65-$3.75 billion and EPS of $3.05-$3.15.
The document reviews Monsanto's R&D pipeline. It notes that 5 projects advanced phases and 5 products were added to the pipeline in the past year. Key milestones include the first time 4 projects moved from Phase 2 to Phase 3 and 2 generations of a corn drought family advancing. The pipeline leverages breeding and biotech for commercial growth and new platforms in the next decade.
Celanese Corporation reported strong financial results for the second quarter and first half of 2006, with net sales increasing 11% compared to the previous year. Operating profit rose 7% for the quarter and 17% for the first half, driven by continued strong demand across business segments. Adjusted earnings per share increased 34% for the quarter and 18% for the first half. All business segments saw higher sales and improved operating performance compared to the previous year.
Oshkosh Truck Corporation presented an investor presentation on its proposed acquisition of JLG Industries, Inc. The presentation discussed Oshkosh's track record of successful acquisitions and shareholder value creation. It also outlined the objectives of acquiring JLG to support growth above 15%, diversify into the fast-growing aerial work platform market, and execute its long-term acquisition strategy. Finally, the presentation provided an overview of Oshkosh Truck Corporation and its proven strategy of new product leadership, operational excellence, and strategic acquisitions that have fueled strong sales and earnings growth.
In this earnings call, Oshkosh Truck Corporation discusses its first quarter 2007 results. Sales increased 27.4% to $1.01 billion due to the acquisition of JLG Industries. Operating income decreased 3.9% to $83.6 million and EPS decreased 23.6% to $0.55. The company increased its full-year 2007 EPS estimate range to $3.15 to $3.25 per share. JLG is meeting expectations and integration is progressing well. Defense sales were lower compared to strong prior year results while fire and emergency and commercial saw strong performance.
The document summarizes Oshkosh Corporation's earnings conference call for the second quarter of fiscal year 2008. Key highlights include sales increasing 6.7% to $1.8 billion and operating income rising 24.8% to $168.2 million. EPS grew 42.6% to $0.97. While access equipment and defense saw strong demand, commercial and fire & emergency faced challenging market conditions. The company maintained its fiscal year 2008 EPS estimate range of $4.15 to $4.35.
- Cummins has doubled revenue over the past 5 years and achieved the highest 3-year period of net earnings as a percent of sales in over 40 years.
- The company has diversified globally and by end markets to reduce cyclicality, aggressively pursued low cost leadership, and built greater earnings stability.
- Cummins is investing in new engine platforms and technologies to capitalize on growth opportunities from evolving global emission standards.
Yahoo's Q1 2008 financial highlights presentation notes that the document discusses forward-looking statements about Yahoo's expected financial performance and strategic plans that are subject to risks and uncertainties, actual results may differ materially from predictions, and reported results should not be considered indicators of future performance. Potential risks include the results of Yahoo's strategic initiatives, competition, reductions in customer spending, demand for premium services, acceptance of new products and services, risks related to joint ventures and acquisitions, and risks related to international operations.
Robert G. Bohn, Chairman, President and CEO of Oshkosh Truck Corporation, discussed the company's strong third quarter fiscal year 2006 results and provided an outlook for fiscal years 2006 and 2007. Some highlights included record sales and operating income for Q3 2006. The company also announced two acquisitions, AK Specialty Vehicles and Iowa Mold Tooling, expected to be accretive to earnings in fiscal 2007. For fiscal 2006, Oshkosh estimates sales growth of 14.9-16.6% and EPS growth of 24-26%. Fiscal 2007 estimates include sales of $3.65-$3.75 billion and EPS of $3.05-$3.15.
The document reviews Monsanto's R&D pipeline. It notes that 5 projects advanced phases and 5 products were added to the pipeline in the past year. Key milestones include the first time 4 projects moved from Phase 2 to Phase 3 and 2 generations of a corn drought family advancing. The pipeline leverages breeding and biotech for commercial growth and new platforms in the next decade.
Celanese Corporation reported strong financial results for the second quarter and first half of 2006, with net sales increasing 11% compared to the previous year. Operating profit rose 7% for the quarter and 17% for the first half, driven by continued strong demand across business segments. Adjusted earnings per share increased 34% for the quarter and 18% for the first half. All business segments saw higher sales and improved operating performance compared to the previous year.
Oshkosh Truck Corporation presented an investor presentation on its proposed acquisition of JLG Industries, Inc. The presentation discussed Oshkosh's track record of successful acquisitions and shareholder value creation. It also outlined the objectives of acquiring JLG to support growth above 15%, diversify into the fast-growing aerial work platform market, and execute its long-term acquisition strategy. Finally, the presentation provided an overview of Oshkosh Truck Corporation and its proven strategy of new product leadership, operational excellence, and strategic acquisitions that have fueled strong sales and earnings growth.
In this earnings call, Oshkosh Truck Corporation discusses its first quarter 2007 results. Sales increased 27.4% to $1.01 billion due to the acquisition of JLG Industries. Operating income decreased 3.9% to $83.6 million and EPS decreased 23.6% to $0.55. The company increased its full-year 2007 EPS estimate range to $3.15 to $3.25 per share. JLG is meeting expectations and integration is progressing well. Defense sales were lower compared to strong prior year results while fire and emergency and commercial saw strong performance.
Robert Bohn, Chairman of Oshkosh Truck Corporation, discussed the company's strong fiscal 2006 financial results and outlook for fiscal 2007. Key points include:
1) Fiscal 2006 sales increased 15.8% and operating income grew 22%, with EPS up 26.6%.
2) The acquisition of JLG Industries was announced, which will diversify the company and support growth of over 15%.
3) Fiscal 2007 stand-alone estimates include sales of $3.65-$3.75 billion and EPS of $3.05-$3.15, with the JLG acquisition expected to be modestly accretive.
1) Orchid Chemicals has acquired US-based generic marketing and sales company Karalex Pharma through an all-cash deal estimated between 2-2.5x Price/Sales.
2) The acquisition will help Orchid establish front-end presence in the US market and launch 15 new generic products over the next few years.
3) The deal is expected to contribute $10 million to Orchid's revenue in FY2011 and $15 million in FY2012, while maintaining EBITDA margins of 17-18%.
Monsanto reported strong financial results for the fourth quarter and fiscal year 2006. Net sales reached record levels for the year, driven by growth in the company's corn and Roundup herbicide businesses. While Monsanto reported a loss for the fourth quarter, it was an improvement over the prior year. For the full fiscal year 2006, the company reported significantly higher net income compared to 2005. Monsanto also generated over $1 billion in free cash flow for the year, reflecting higher profits and lower acquisition spending. Looking ahead, the company expects continued growth from its seeds and traits businesses to support further earnings expansion.
Procter & Gamble reported financial results for the second quarter of fiscal year 2013, with organic sales growth of 6% overall. All reporting segments saw organic sales growth between 2-5%. Market share trends improved or were in-line for most categories. Core earnings per share grew 12% for the quarter, driven by top-line sales growth and productivity savings. For fiscal year 2013, the company increased guidance for organic sales growth to 3-4% and raised the core earnings per share growth outlook.
Raytheon Reports 2006 First Quarter Resultsfinance12
Raytheon reported strong first quarter results in 2006. Bookings were $5.5 billion, a record backlog of $34.7 billion, and earnings per share increased 49% over the prior year. Raytheon also increased its full-year guidance for earnings per share, operating cash flow, and return on invested capital. The document provides details on Raytheon's financial outlook for 2006 by business, cash flow, quarterly results, and government and defense segment.
1) Oshkosh reported record second quarter fiscal year 2006 results with sales up 25.6% and operating income up 27.3% driven by strong performance in the defense segment.
2) The defense segment results nearly doubled compared to the previous year due to growth in remanufactured and new truck sales, however challenges remain in locating used vehicle carcasses for remanufacturing.
3) The fire and emergency segment saw a temporary dip in earnings as anticipated due to heavily weighted airport product sales in the second half of the year and two component issues that delayed revenue recognition.
Robert G. Bohn, Chairman, President and CEO of Oshkosh Truck Corporation, and Charles L. Szews, Executive VP and CFO, reported record financial results for the first quarter of fiscal year 2006. Sales increased 22.5% to $790.3 million and operating income grew 28.6% to $87 million. EPS increased 28.6% to $0.72. For fiscal year 2006, the company estimates sales between $3.3-3.4 billion, operating income between $316.5-329 million, and EPS between $2.55-2.65, representing growth of 17-21.6%.
This document summarizes an earnings conference call for Oshkosh Truck Corporation for the second quarter of fiscal year 2007. Sales increased 96.6% to $1.66 billion and operating income grew 69.1% to $134.8 million. For fiscal year 2007, the company estimates sales of $6.1-6.2 billion and operating income of $568-580 million. It also provides segment-level results and highlights for access equipment, defense, fire & emergency, and commercial.
1) The document discusses Rohm and Haas' third quarter 2008 earnings results. Sales were up 12% to $2,471 million due to pricing actions, currency effects, acquisitions, and growth in rapidly developing economies, despite decreased demand in North America and Western Europe.
2) Adjusted earnings per share were up 3% to $0.90 due to cost controls and pricing actions offsetting deteriorating business conditions.
3) The Dow Chemical Company announced a definitive agreement to acquire Rohm and Haas for $78 per share in cash on July 10, 2008.
Celanese Corporation reported record results in the first quarter of 2006, with net sales up 12% and operating profit up 26% compared to the same period last year. Diluted earnings per share were $0.68 compared to a loss of ($0.08) in 2005. The company reaffirmed its guidance for adjusted earnings per share of between $2.50-$2.90 for 2006.
- Monsanto reported a 10% increase in net sales for the first quarter of fiscal year 2007 compared to the same period in 2006, driven by growth in its U.S. corn seed and traits business and increased sales of Roundup herbicides.
- Net income for the quarter was $90 million, up from $59 million in the prior year. Earnings per share were $0.16 for both reported and ongoing business.
- For the full fiscal year 2007, Monsanto expects earnings per share toward the upper end of its previous guidance range of $1.50 to $1.57 and free cash flow between $875-950 million.
Goodrich Corporation reported third quarter 2007 results with year-over-year sales growth of 15% and segment operating income margin expansion of 2.7 percentage points to 17.2%. Income per diluted share from continuing operations increased 39% compared to third quarter 2006. The company also provided outlook for full year 2007 with sales estimated at $6.4-6.5 billion and income per diluted share from continuing operations of $3.65-3.70, up from prior estimates. Full year 2008 outlook estimates sales growth of approximately 11% over 2007 with income per diluted share growth of 12-16%.
- Net sales increased significantly from $4.74 billion in 1999 to $7.13 billion in 2000. Net income increased slightly from $515.8 million in 1999 to $422 million in 2000.
- The Telecommunications segment saw the largest increase in revenues from $2.96 billion in 1999 to $5.12 billion in 2000, driving the overall revenue growth.
- Pro forma diluted earnings per share, which excludes certain one-time items, increased from $0.67 in 1999 to $1.23 in 2000 despite a smaller increase in net income, reflecting share repurchases.
The 2000 Annual Report summarizes Henry Schein's financial performance and operations. It states that Henry Schein is the largest distributor of healthcare products and services in North America and Europe, serving over 650,000 practitioners. The report highlights that net sales increased to $2.38 billion in 2000, operating income grew to $127.6 million, and earnings per share rose to $1.67. It also details Henry Schein's distribution network and capabilities.
Henry Schein is celebrating its 75th anniversary. It has grown from a small pharmacy founded during the Great Depression to a Fortune 500 company and the largest distributor of healthcare products to office-based practitioners in North America and Europe. Over the years, Henry Schein has expanded through acquisitions, increased its product and service offerings, and provided innovative solutions to help customers run successful practices. Looking to the future, Henry Schein aims to continue growing strategically while preserving its values and commitment to customers, employees, and communities.
Henry Schein is the largest distributor of healthcare products and services to office-based healthcare practitioners in North America and Europe. In 2002, Henry Schein achieved record financial results with net sales of $2.8 billion, operating income of $196 million, and net income of $117 million. The company expects continued growth through increasing penetration of existing customers, gaining new customers, and cross-selling between its business groups that serve the dental, medical, veterinary, and technology markets.
This annual report summarizes Corning Inc.'s financial performance in 2001, which saw a significant downturn from 2000 due to challenging conditions in the telecommunications sector and global economic weakness. Net sales fell 12% to $6.3 billion and the company reported a net loss of $5.5 billion compared to net income of $409 million in 2000. Corning took actions to reduce costs, including eliminating 12,000 jobs and closing plants. However, the company ended 2001 with $2.2 billion in cash and believes it is well positioned financially and strategically for long-term growth opportunities in key markets like optical fiber and displays.
Health & Medicine Policy Research Group hosted a forum, “Health Reform and the Health Care Safety Net: Challenges and Opportunities,” on July 9 to explore the potential impact of health reform on the health care safety net nationally and in Illinois specifically.
The forum explored challenges and opportunities presented by health reform in Illinois, and examined the impact on community health centers, safety net hospitals, the health workforce, and vulnerable populations. Speakers included
*Michael McRaith, Director, Illinois Department of Insurance
*Julie Hamos, Director, Illinois Department of Healthcare and Family Services
*Claudine Swartz, Assistant Vice President for Policy, National Association of Public Hospitals and Health Systems (NAPH)
*Bill Foley, CEO, Cook County Health & Hospitals System
*Philippe Largent, VP for Government Affairs, IL Primary Healthcare Association
*Linda Murray, Chief Medical Officer, Cook County Department of Public Health, President-Elect, APHA
*Roberta Rakove, Senior Vice President, Government Affairs, Sinai Health System
This document summarizes the services provided by Accountable Care Solutions Group (ACSG) to support Accountable Care Organizations (ACOs). ACSG utilizes the American Health Data Institute (AHDI) to provide data analytics, population health management, and cost/quality reporting. ACSG's patented population management processes can help ACOs manage healthcare costs and quality. ACSG can also support ACO infrastructure, operations, financial reporting, and deployment of employer-based population health programs.
Universal Health Services is one of the largest hospital management companies in the US. In 2004, revenues grew 16% to $3.9 billion but net income fell 15% due to rising bad debt. UHS is addressing challenges by expanding facilities, investing in new technologies, and focusing on high-quality care. Recent growth strategies included opening new hospitals, expanding existing facilities, and acquiring hospitals in growing markets.
Universal Health Services is one of the largest hospital management companies in the US. In 2004, revenues grew 16% to $3.9 billion but net income fell 15% due to rising bad debt. UHS is addressing challenges by expanding facilities, investing in new technologies, and focusing on high-quality care. Recent growth strategies included opening new hospitals, expanding existing facilities, and acquiring hospitals in growing markets.
bristol myerd squibb Deutsche Bank Securities Inc. Health Care Conferencefinance13
Lamberto Andreotti, Chief Operating Officer of Bristol-Myers Squibb, presented at the Deutsche Bank Healthcare Conference on May 7, 2008. He discussed Bristol-Myers Squibb's strong Q1 2008 performance with 9% underlying sales growth and improved margins. He highlighted several drugs like Plavix, Abilify, and Orencia that showed significant sales increases. Andreotti also outlined Bristol-Myers Squibb's approach to productivity improvements through redesigning supply chain operations, restructuring customer models, and R&D transformation to generate $1.5 billion in savings.
Robert Bohn, Chairman of Oshkosh Truck Corporation, discussed the company's strong fiscal 2006 financial results and outlook for fiscal 2007. Key points include:
1) Fiscal 2006 sales increased 15.8% and operating income grew 22%, with EPS up 26.6%.
2) The acquisition of JLG Industries was announced, which will diversify the company and support growth of over 15%.
3) Fiscal 2007 stand-alone estimates include sales of $3.65-$3.75 billion and EPS of $3.05-$3.15, with the JLG acquisition expected to be modestly accretive.
1) Orchid Chemicals has acquired US-based generic marketing and sales company Karalex Pharma through an all-cash deal estimated between 2-2.5x Price/Sales.
2) The acquisition will help Orchid establish front-end presence in the US market and launch 15 new generic products over the next few years.
3) The deal is expected to contribute $10 million to Orchid's revenue in FY2011 and $15 million in FY2012, while maintaining EBITDA margins of 17-18%.
Monsanto reported strong financial results for the fourth quarter and fiscal year 2006. Net sales reached record levels for the year, driven by growth in the company's corn and Roundup herbicide businesses. While Monsanto reported a loss for the fourth quarter, it was an improvement over the prior year. For the full fiscal year 2006, the company reported significantly higher net income compared to 2005. Monsanto also generated over $1 billion in free cash flow for the year, reflecting higher profits and lower acquisition spending. Looking ahead, the company expects continued growth from its seeds and traits businesses to support further earnings expansion.
Procter & Gamble reported financial results for the second quarter of fiscal year 2013, with organic sales growth of 6% overall. All reporting segments saw organic sales growth between 2-5%. Market share trends improved or were in-line for most categories. Core earnings per share grew 12% for the quarter, driven by top-line sales growth and productivity savings. For fiscal year 2013, the company increased guidance for organic sales growth to 3-4% and raised the core earnings per share growth outlook.
Raytheon Reports 2006 First Quarter Resultsfinance12
Raytheon reported strong first quarter results in 2006. Bookings were $5.5 billion, a record backlog of $34.7 billion, and earnings per share increased 49% over the prior year. Raytheon also increased its full-year guidance for earnings per share, operating cash flow, and return on invested capital. The document provides details on Raytheon's financial outlook for 2006 by business, cash flow, quarterly results, and government and defense segment.
1) Oshkosh reported record second quarter fiscal year 2006 results with sales up 25.6% and operating income up 27.3% driven by strong performance in the defense segment.
2) The defense segment results nearly doubled compared to the previous year due to growth in remanufactured and new truck sales, however challenges remain in locating used vehicle carcasses for remanufacturing.
3) The fire and emergency segment saw a temporary dip in earnings as anticipated due to heavily weighted airport product sales in the second half of the year and two component issues that delayed revenue recognition.
Robert G. Bohn, Chairman, President and CEO of Oshkosh Truck Corporation, and Charles L. Szews, Executive VP and CFO, reported record financial results for the first quarter of fiscal year 2006. Sales increased 22.5% to $790.3 million and operating income grew 28.6% to $87 million. EPS increased 28.6% to $0.72. For fiscal year 2006, the company estimates sales between $3.3-3.4 billion, operating income between $316.5-329 million, and EPS between $2.55-2.65, representing growth of 17-21.6%.
This document summarizes an earnings conference call for Oshkosh Truck Corporation for the second quarter of fiscal year 2007. Sales increased 96.6% to $1.66 billion and operating income grew 69.1% to $134.8 million. For fiscal year 2007, the company estimates sales of $6.1-6.2 billion and operating income of $568-580 million. It also provides segment-level results and highlights for access equipment, defense, fire & emergency, and commercial.
1) The document discusses Rohm and Haas' third quarter 2008 earnings results. Sales were up 12% to $2,471 million due to pricing actions, currency effects, acquisitions, and growth in rapidly developing economies, despite decreased demand in North America and Western Europe.
2) Adjusted earnings per share were up 3% to $0.90 due to cost controls and pricing actions offsetting deteriorating business conditions.
3) The Dow Chemical Company announced a definitive agreement to acquire Rohm and Haas for $78 per share in cash on July 10, 2008.
Celanese Corporation reported record results in the first quarter of 2006, with net sales up 12% and operating profit up 26% compared to the same period last year. Diluted earnings per share were $0.68 compared to a loss of ($0.08) in 2005. The company reaffirmed its guidance for adjusted earnings per share of between $2.50-$2.90 for 2006.
- Monsanto reported a 10% increase in net sales for the first quarter of fiscal year 2007 compared to the same period in 2006, driven by growth in its U.S. corn seed and traits business and increased sales of Roundup herbicides.
- Net income for the quarter was $90 million, up from $59 million in the prior year. Earnings per share were $0.16 for both reported and ongoing business.
- For the full fiscal year 2007, Monsanto expects earnings per share toward the upper end of its previous guidance range of $1.50 to $1.57 and free cash flow between $875-950 million.
Goodrich Corporation reported third quarter 2007 results with year-over-year sales growth of 15% and segment operating income margin expansion of 2.7 percentage points to 17.2%. Income per diluted share from continuing operations increased 39% compared to third quarter 2006. The company also provided outlook for full year 2007 with sales estimated at $6.4-6.5 billion and income per diluted share from continuing operations of $3.65-3.70, up from prior estimates. Full year 2008 outlook estimates sales growth of approximately 11% over 2007 with income per diluted share growth of 12-16%.
- Net sales increased significantly from $4.74 billion in 1999 to $7.13 billion in 2000. Net income increased slightly from $515.8 million in 1999 to $422 million in 2000.
- The Telecommunications segment saw the largest increase in revenues from $2.96 billion in 1999 to $5.12 billion in 2000, driving the overall revenue growth.
- Pro forma diluted earnings per share, which excludes certain one-time items, increased from $0.67 in 1999 to $1.23 in 2000 despite a smaller increase in net income, reflecting share repurchases.
The 2000 Annual Report summarizes Henry Schein's financial performance and operations. It states that Henry Schein is the largest distributor of healthcare products and services in North America and Europe, serving over 650,000 practitioners. The report highlights that net sales increased to $2.38 billion in 2000, operating income grew to $127.6 million, and earnings per share rose to $1.67. It also details Henry Schein's distribution network and capabilities.
Henry Schein is celebrating its 75th anniversary. It has grown from a small pharmacy founded during the Great Depression to a Fortune 500 company and the largest distributor of healthcare products to office-based practitioners in North America and Europe. Over the years, Henry Schein has expanded through acquisitions, increased its product and service offerings, and provided innovative solutions to help customers run successful practices. Looking to the future, Henry Schein aims to continue growing strategically while preserving its values and commitment to customers, employees, and communities.
Henry Schein is the largest distributor of healthcare products and services to office-based healthcare practitioners in North America and Europe. In 2002, Henry Schein achieved record financial results with net sales of $2.8 billion, operating income of $196 million, and net income of $117 million. The company expects continued growth through increasing penetration of existing customers, gaining new customers, and cross-selling between its business groups that serve the dental, medical, veterinary, and technology markets.
This annual report summarizes Corning Inc.'s financial performance in 2001, which saw a significant downturn from 2000 due to challenging conditions in the telecommunications sector and global economic weakness. Net sales fell 12% to $6.3 billion and the company reported a net loss of $5.5 billion compared to net income of $409 million in 2000. Corning took actions to reduce costs, including eliminating 12,000 jobs and closing plants. However, the company ended 2001 with $2.2 billion in cash and believes it is well positioned financially and strategically for long-term growth opportunities in key markets like optical fiber and displays.
Health & Medicine Policy Research Group hosted a forum, “Health Reform and the Health Care Safety Net: Challenges and Opportunities,” on July 9 to explore the potential impact of health reform on the health care safety net nationally and in Illinois specifically.
The forum explored challenges and opportunities presented by health reform in Illinois, and examined the impact on community health centers, safety net hospitals, the health workforce, and vulnerable populations. Speakers included
*Michael McRaith, Director, Illinois Department of Insurance
*Julie Hamos, Director, Illinois Department of Healthcare and Family Services
*Claudine Swartz, Assistant Vice President for Policy, National Association of Public Hospitals and Health Systems (NAPH)
*Bill Foley, CEO, Cook County Health & Hospitals System
*Philippe Largent, VP for Government Affairs, IL Primary Healthcare Association
*Linda Murray, Chief Medical Officer, Cook County Department of Public Health, President-Elect, APHA
*Roberta Rakove, Senior Vice President, Government Affairs, Sinai Health System
This document summarizes the services provided by Accountable Care Solutions Group (ACSG) to support Accountable Care Organizations (ACOs). ACSG utilizes the American Health Data Institute (AHDI) to provide data analytics, population health management, and cost/quality reporting. ACSG's patented population management processes can help ACOs manage healthcare costs and quality. ACSG can also support ACO infrastructure, operations, financial reporting, and deployment of employer-based population health programs.
Universal Health Services is one of the largest hospital management companies in the US. In 2004, revenues grew 16% to $3.9 billion but net income fell 15% due to rising bad debt. UHS is addressing challenges by expanding facilities, investing in new technologies, and focusing on high-quality care. Recent growth strategies included opening new hospitals, expanding existing facilities, and acquiring hospitals in growing markets.
Universal Health Services is one of the largest hospital management companies in the US. In 2004, revenues grew 16% to $3.9 billion but net income fell 15% due to rising bad debt. UHS is addressing challenges by expanding facilities, investing in new technologies, and focusing on high-quality care. Recent growth strategies included opening new hospitals, expanding existing facilities, and acquiring hospitals in growing markets.
bristol myerd squibb Deutsche Bank Securities Inc. Health Care Conferencefinance13
Lamberto Andreotti, Chief Operating Officer of Bristol-Myers Squibb, presented at the Deutsche Bank Healthcare Conference on May 7, 2008. He discussed Bristol-Myers Squibb's strong Q1 2008 performance with 9% underlying sales growth and improved margins. He highlighted several drugs like Plavix, Abilify, and Orencia that showed significant sales increases. Andreotti also outlined Bristol-Myers Squibb's approach to productivity improvements through redesigning supply chain operations, restructuring customer models, and R&D transformation to generate $1.5 billion in savings.
bristol myerd squibb Merrill Lynch Global Pharmaceutical Conferencefinance13
Jean-Marc Huët, Senior Vice President and Chief Financial Officer of Bristol-Myers Squibb, presented at the Merrill Lynch Global Healthcare Conference in London on September 16, 2008. He discussed Bristol-Myers Squibb's transition of its portfolio through acquisitions and sales of companies in 2008. Huët also highlighted strong sales growth and improving margins in the second quarter of 2008 driven by top products like Plavix, Abilify, and Orencia. Finally, he laid out Bristol-Myers Squibb's strategy to deliver growth in three stages through commercial execution, productivity initiatives, and progressing its pipeline of potential new drugs.
1) Monsanto projects double-digit earnings growth in 2008, with ongoing EPS expected to increase 25-30% from 2007 levels.
2) Gross profit is targeted to more than double from 2007 levels to over $9 billion by 2012 through organic growth of its base business and R&D pipeline, focusing on areas like US corn, soybeans, and cotton.
3) Strong cash generation is expected in 2008 with free cash flow projected between $900 million to $1 billion, and capital expenditures increasing to over $800 million.
The document provides an overview and update of Monsanto's research and development pipeline. Key points include:
- 5 projects advanced phases in the biotech trait pipeline and 5 new products were added.
- DEKALB corn maintained a 8.4 bushel per acre yield advantage on average compared to competitors. When protected with YieldGard VT Triple, the advantage widened to 14.6 bushels.
- Roundup Ready2Yield soybeans and molecular breeding are expected to significantly increase soybean yields above historic trends.
- The drought tolerant corn family and nitrogen utilization corn family projects were advanced in the pipeline.
Moss Adams 2007 Personal Financial Planning Practice Studyhilldor
The document summarizes a study on CPA financial planning practices. It finds that CPA financial planning practices are growing faster than the broader financial planning industry, averaging 34.9% annual growth. Most successful firms develop formal plans and goals, monitor performance of their financial planning services, formalize compensation systems, and devote time to marketing. The study provides insights into the structures, registrations, challenges and opportunities for CPA financial planning practices.
Ideiasnet is a Brazilian business development company focused on long-term investments in IT. It has both private equity and venture capital arms. The private equity side focuses on larger investments in proven businesses for consolidation and growth. The venture capital side, Ideias Ventures, invests in early-stage companies with under R$10M in revenue to provide support for entrepreneurship. Ideiasnet aims to create synergies across its growing portfolio of IT companies.
- The annual report summarizes AutoZone's fiscal year 2002 performance, which saw record sales of $5.3 billion, earnings per share of $4.00, and a 52% return for shareholders.
- The three divisions - U.S. Retail, AZ Commercial, and Mexico - all contributed to growth. U.S. Retail had same-store sales growth of 8% and now operates 3,068 stores across 44 states.
- AZ Commercial grew 20% to $532 million in sales by expanding commercial product offerings and dedicated sales force for commercial customers.
- AutoZone aims to continue delivering strong profitable growth and pursuing opportunities in the large market for automotive maintenance and repairs.
The document appears to be a portfolio from Lawrence Samuels including details about his skills in corporate valuation, accounting, statistics, and additional tools. It includes a case study and analysis of Thumbs Up Corporation, a company that launched two projects to generate buzz about new products and establish a customer base. Samuels provides forecasts and analyses of Thumbs Up Corporation's sales, budgets, expansion projects, and marketing strategies.
- UHS acquired its 100th facility in 2002, a hospital in Lansdale, PA called Central Montgomery Medical Center.
- Construction began on 4 new hospitals - in Las Vegas, Amarillo, Wellington FL, and Lakewood Ranch FL.
- The new George Washington University Hospital opened in Washington D.C. in 2002 after a partnership between UHS and GWU. There was initial skepticism that UHS would prioritize profits over quality that was overcome.
This annual report summarizes Universal Health Services' financial results and activities in 2002. Some key points:
- Net revenues increased 15% to $3.258 billion and net income increased 76% to $175.36 million. Earnings per share increased 71% to $2.74.
- UHS acquired its 100th facility, a hospital in Lansdale, Pennsylvania, becoming its first acute care facility in that state.
- Construction began on new hospitals in Las Vegas, Nevada and Amarillo, Texas, continuing UHS' expansion and growth.
- Overall it was a very successful year financially for UHS, with continued growth and new records set.
Lennar Corporation grew significantly in 1998 through adherence to core values and strategies of operational simplicity, strategic acquisitions, diversified earnings, and balance sheet strength. Key accomplishments included 73% earnings per share growth, reduced homebuilding debt ratio, and 63% increased shareholders' equity. Lennar's simple operating model of focused geographic markets, standardized home features, and emphasis on quality helped drive efficient growth. Acquisitions expanded operations across high-growth states while diversifying earnings. Maintaining a prudent balance sheet positions Lennar for continued long-term growth.
Lennar Corporation grew significantly from 1996-1998 through strategic acquisitions, geographic expansion, product and service diversification, and strengthening of its balance sheet. It grew revenues from $1.4 billion to $2.4 billion, net income from $59.8 million to $144.1 million, and earnings per share from $1.12 to $2.49 over this period. Lennar focused on building high quality homes across a range of price points for first-time buyers, move-up buyers, and active adults in the fastest growing markets of Florida, Texas, Arizona, Nevada, and California. It also expanded its financial services offerings. Lennar emphasized keeping operations simple and leveraging its
MeadWestvaco presented at the JPMorgan Third Annual Basics & Industrials Conference. The presentation focused on MeadWestvaco's transformation into a global packaging leader, opportunities for margin expansion through productivity initiatives and pricing power, and its land business strategy to deliver new cash flows. MeadWestvaco believes these factors position it well for continued profitable growth and make it an attractive investment.
MeadWestvaco presented at the JPMorgan Third Annual Basics & Industrials Conference. The presentation focused on MeadWestvaco's transformation into a global packaging leader, opportunities for margin expansion through productivity initiatives and pricing power, and its land business strategy to deliver new cash flows. MeadWestvaco believes these factors position it well for continued profitable growth and make it an attractive investment.
The document promotes joining the management team of The Assurance Group insurance company. It outlines the company's history and financial strength. It provides examples of high potential earnings for agents and agency directors, including over $4,000 per week for agency directors with 10 active agents. The document emphasizes training, support, advancement opportunities, and earning according to one's efforts as benefits of the opportunity.
Socially Responsible Investing at TIAA-CREFfinance9
TIAA-CREF has a long-standing commitment to socially responsible investing through three complementary strategies: social screening of investment options to align portfolios with investor values, shareholder advocacy to promote sound corporate governance, and community investing to help meet local needs. The document provides an overview of each strategy, including growth in socially screened assets, the screening process, international expansion of the CREF Social Choice Account, proxy voting practices, and engagement on key issues like climate change and human rights. It highlights TIAA-CREF's leadership in transparent proxy voting disclosure and integrating shareholder activism across its portfolio.
Masco Corporation's 2001 annual report summarizes the company's financial results and business operations for the year. Key points include:
- Net sales reached a record $8.3 billion, up 15% from 2000, though net income declined to $199 million due to a $344 million non-cash investment write-down. Excluding special items, net income declined 21% to $543 million.
- The company achieved record operating profit exceeding $1 billion despite economic challenges. Capital expenditures totaled $274 million.
- Sales growth was driven by acquisitions expanding the cabinets/related products and installation/services segments, though plumbing product sales declined 5%.
- Most of Masco's
This financial review provides operating and financial information for Northeast Utilities (NU) and its subsidiaries through June 30, 2008. Key information includes:
- NU's consolidated revenues for 2007 were $5.822 billion and operating income was $539 million.
- The largest subsidiary, The Connecticut Light and Power Company (CL&P), had revenues of $3.682 billion in 2007 and operating income of $285 million.
- Financial information such as sales, revenues, income, capitalization, debt ratings and dividend payments are presented for NU, CL&P and other subsidiaries from 2007 back to 2003.
1. The 2008 Annual Meeting of Shareholders of Northeast Utilities will be held on May 13, 2008 at 10:30am at the offices of Public Service Company of New Hampshire.
2. Matters to be voted on include electing 12 trustee nominees and ratifying the selection of Deloitte & Touche LLP as the independent auditors for 2008.
3. Directions to the meeting location in Manchester, NH are provided. Shareholders are urged to vote their shares whether attending the meeting or not.
The annual report summarizes Corning's financial performance in 2002, a challenging year due to the downturn in the telecommunications industry. Corning reported a net loss of $1.3 billion on sales of $3.2 billion, down significantly from 2001. In response, Corning restructured operations, cutting costs and jobs to preserve its financial position. It aims to return to profitability in 2003 by focusing on growing its display glass, environmental, and semiconductor businesses within Corning Technologies. While telecommunications remains weak, Corning maintains its leadership in optical fiber and intends to benefit when the market rebounds.
Corning Inc. is a 152-year-old diversified technology company that focuses on high-impact growth opportunities through specialty glass, ceramics, polymers, and light manipulation. It develops innovative products for telecommunications, displays, environmental, life sciences, semiconductors, and other materials markets. The 2003 annual report discusses priorities of protecting financial health, returning to profitability, and continuing to invest in the future. It emphasizes growth through global innovation, achieving balance and stability, and preserving trust through living the company's values.
The document is Corning's 2006 Annual Report and 2007 Proxy Statement. It provides an overview of Corning's financial performance and highlights in 2006, including record net income and earnings per share. It discusses Corning's strategies of protecting financial health, improving profitability, and investing in the future. It also outlines Corning's leadership transition with Wendell Weeks becoming Chairman and CEO and Peter Volanakis becoming President. Key financial figures for 2006 show net sales of $5.17 billion and net income of $1.85 billion, up significantly from 2005.
Corning Inc. reported strong financial performance in its 2007 Annual Report. Net income reached an all-time high of $2.15 billion, up 16% from 2006. Sales increased 13% to $5.86 billion, driven by high demand for LCD glass and new diesel filtration products. Corning also achieved records for earnings per share at $1.34 and operating cash flow at $2.1 billion. The report discusses Corning's strategy of focusing on innovation to drive growth, maintaining financial stability, and improving business portfolio balance. Key accomplishments in 2007 included expanding LCD glass capacity and developing innovations in optical fiber and life sciences technologies.
Corning posted record performance in the first half of 2008 but experienced weak performance in the second half due to the global recession. While sales were up 21% in the first half, they declined 30% in the fourth quarter compared to the third quarter and previous year. Corning implemented cost-cutting measures like job cuts and spending reductions to prepare for a weak 2009. However, Corning remains confident in its long-term strategies and innovative products to drive future growth once the economy recovers.
Atmos Energy Corporation is a natural gas distribution and pipeline company headquartered in Dallas, Texas. In fiscal year 2008, the company reported $180.3 million in net income on $7.2 billion in operating revenues. Atmos Energy distributes natural gas to 3.2 million customers across 12 states and owns one of the largest intrastate pipeline systems in Texas. The company has grown through acquisitions, adding over 2.9 million customers since 1983, and pursues a strategy of growing its regulated and complementary nonregulated natural gas businesses.
Atmos Energy Corporation will host a conference call on February 4, 2009 at 8:00 am ET to discuss its fiscal 2009 first quarter financial results. Atmos Energy, headquartered in Dallas, is the largest natural gas-only distributor in the US, serving about 3.2 million customers across 12 states. Interested parties can access the conference call by dialing 800-218-0204 or listening online at Atmos Energy's website, where an archive of the call will also be made available until April 30, 2009.
Atmos Energy Corporation reported earnings for the first quarter of fiscal year 2009. Net income was $76.0 million, up slightly from $73.8 million in the prior year. Regulated gas distribution operations contributed $57.8 million in net income, up 25% from the prior year. The company affirmed its fiscal year 2009 earnings guidance of $2.05 to $2.15 per share, excluding mark-to-market impacts. Capital expenditures for the year are expected to be $500-$515 million.
Atmos Energy Corporation declared a quarterly dividend of 33 cents per share to shareholders of record on February 25, 2009. This marks the company's 101st consecutive quarterly dividend. Atmos Energy is the country's largest natural-gas-only distributor, serving about 3.2 million customers across 12 states. It also provides natural gas marketing and pipeline management services.
Fred Meisenheimer was promoted to senior vice president and chief financial officer of Atmos Energy Corporation. Meisenheimer has been acting as interim CFO since January 1, 2009. He joined Atmos Energy in 2000 as vice president and controller and has made valuable contributions to the company's success over eight years. Prior to joining Atmos Energy, Meisenheimer held financial and accounting roles at other energy companies.
Atmos Energy Corporation is a natural gas distribution and pipeline company headquartered in Dallas, Texas. In fiscal year 2008, the company reported $180.3 million in net income on $7.2 billion in operating revenues. Atmos Energy distributes natural gas to 3.2 million customers in 1,600 communities across 8 states. The company has grown significantly through acquisitions, adding over 2.7 million customers since 1983. Atmos Energy aims to continue growing its regulated natural gas distribution operations and complementary nonregulated energy businesses.
This document provides an overview of the nonutility operations of Atmos Energy Corporation. It discusses the corporate structure and business segments, including gas marketing, pipeline and storage, and other nonutility operations. It then provides more detailed descriptions of the storage business models, including proprietary storage, full requirements storage, billable plan storage, and parking and loaning transactions. The storage business models are explained in terms of associated risks, risk management strategies, and impact on margins.
The document discusses forward-looking statements and risks associated with them. It provides an overview of Atmos Energy, including its scope of operations across 12 states in the utility segment and 22 states in the nonutility segment. It also summarizes Atmos Energy's financial and operational performance over time, including earnings growth, dividend increases, and acquisition history such as the purchase of TXU Gas.
A conference call was scheduled for February 8, 2006 at 8:00 am EST to review the company's fiscal 2006 first quarter financial results. The company reported a net income of $100 million, up 19% from the prior year quarter. Earnings per share were $0.88, up 11% from the previous year. Key drivers included a contribution from acquisitions and weather that was colder than the prior year. The utility segment saw higher throughput and gross profit.
The document summarizes a conference call to review the company's fiscal 2006 second quarter financial results. Key points from the quarter include a 1.3% increase in net income compared to the prior year quarter, driven by higher contributions from the natural gas marketing segment due to favorable storage and marketing positions. Earnings per share increased 1.3% while operating expenses rose due to higher employee, bad debt, and regulatory costs. Weather during the quarter was warmer than normal, negatively impacting utility throughput.
The document discusses a conference call to review the company's fiscal 2006 third quarter financial results. It provides details on the company's net income, earnings per share, capital expenditures, and performance by business segment for the quarter. The company reported a net loss for the quarter, driven by unrealized mark-to-market losses in natural gas marketing and warmer than normal weather across many utility divisions.
The document summarizes the company's financial results for fiscal year 2006. Key points include:
- Net income increased 20% to $170 million due to higher contributions from nonutility businesses and rate increases.
- Earnings per share increased 16% to $2.00, despite warmer than normal weather reducing utility revenues.
- Gross profit increased $98.9 million primarily from higher natural gas marketing margins and increased pipeline volumes.
- Higher O&M and interest expenses partially offset revenue gains. Overall the company delivered results within its guidance range for the year.
The document summarizes a conference call to review the company's financial results for the first quarter of fiscal year 2007. Key highlights included a 14.5% increase in net income compared to the same period last year, driven by increased contributions from nonutility businesses. Earnings per share were up 10% year-over-year. Capital expenditures totaled $65.2 million for maintenance and $21.8 million for growth. The company also completed a common stock offering in December, raising $192 million in net proceeds.
South Dakota State University degree offer diploma Transcriptynfqplhm
办理美国SDSU毕业证书制作南达科他州立大学假文凭定制Q微168899991做SDSU留信网教留服认证海牙认证改SDSU成绩单GPA做SDSU假学位证假文凭高仿毕业证GRE代考如何申请南达科他州立大学South Dakota State University degree offer diploma Transcript
A toxic combination of 15 years of low growth, and four decades of high inequality, has left Britain poorer and falling behind its peers. Productivity growth is weak and public investment is low, while wages today are no higher than they were before the financial crisis. Britain needs a new economic strategy to lift itself out of stagnation.
Scotland is in many ways a microcosm of this challenge. It has become a hub for creative industries, is home to several world-class universities and a thriving community of businesses – strengths that need to be harness and leveraged. But it also has high levels of deprivation, with homelessness reaching a record high and nearly half a million people living in very deep poverty last year. Scotland won’t be truly thriving unless it finds ways to ensure that all its inhabitants benefit from growth and investment. This is the central challenge facing policy makers both in Holyrood and Westminster.
What should a new national economic strategy for Scotland include? What would the pursuit of stronger economic growth mean for local, national and UK-wide policy makers? How will economic change affect the jobs we do, the places we live and the businesses we work for? And what are the prospects for cities like Glasgow, and nations like Scotland, in rising to these challenges?
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...sameer shah
Delve into the world of STREETONOMICS, where a team of 7 enthusiasts embarks on a journey to understand unorganized markets. By engaging with a coffee street vendor and crafting questionnaires, this project uncovers valuable insights into consumer behavior and market dynamics in informal settings."
Discover the Future of Dogecoin with Our Comprehensive Guidance36 Crypto
Learn in-depth about Dogecoin's trajectory and stay informed with 36crypto's essential and up-to-date information about the crypto space.
Our presentation delves into Dogecoin's potential future, exploring whether it's destined to skyrocket to the moon or face a downward spiral. In addition, it highlights invaluable insights. Don't miss out on this opportunity to enhance your crypto understanding!
https://36crypto.com/the-future-of-dogecoin-how-high-can-this-cryptocurrency-reach/
Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...AntoniaOwensDetwiler
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
University of North Carolina at Charlotte degree offer diploma Transcripttscdzuip
办理美国UNCC毕业证书制作北卡大学夏洛特分校假文凭定制Q微168899991做UNCC留信网教留服认证海牙认证改UNCC成绩单GPA做UNCC假学位证假文凭高仿毕业证GRE代考如何申请北卡罗莱纳大学夏洛特分校University of North Carolina at Charlotte degree offer diploma Transcript
In a tight labour market, job-seekers gain bargaining power and leverage it into greater job quality—at least, that’s the conventional wisdom.
Michael, LMIC Economist, presented findings that reveal a weakened relationship between labour market tightness and job quality indicators following the pandemic. Labour market tightness coincided with growth in real wages for only a portion of workers: those in low-wage jobs requiring little education. Several factors—including labour market composition, worker and employer behaviour, and labour market practices—have contributed to the absence of worker benefits. These will be investigated further in future work.
Economic Risk Factor Update: June 2024 [SlideShare]Commonwealth
May’s reports showed signs of continued economic growth, said Sam Millette, director, fixed income, in his latest Economic Risk Factor Update.
For more market updates, subscribe to The Independent Market Observer at https://blog.commonwealth.com/independent-market-observer.
Enhancing Asset Quality: Strategies for Financial Institutionsshruti1menon2
Ensuring robust asset quality is not just a mere aspect but a critical cornerstone for the stability and success of financial institutions worldwide. It serves as the bedrock upon which profitability is built and investor confidence is sustained. Therefore, in this presentation, we delve into a comprehensive exploration of strategies that can aid financial institutions in achieving and maintaining superior asset quality.
Fabular Frames and the Four Ratio ProblemMajid Iqbal
Digital, interactive art showing the struggle of a society in providing for its present population while also saving planetary resources for future generations. Spread across several frames, the art is actually the rendering of real and speculative data. The stereographic projections change shape in response to prompts and provocations. Visitors interact with the model through speculative statements about how to increase savings across communities, regions, ecosystems and environments. Their fabulations combined with random noise, i.e. factors beyond control, have a dramatic effect on the societal transition. Things get better. Things get worse. The aim is to give visitors a new grasp and feel of the ongoing struggles in democracies around the world.
Stunning art in the small multiples format brings out the spatiotemporal nature of societal transitions, against backdrop issues such as energy, housing, waste, farmland and forest. In each frame we see hopeful and frightful interplays between spending and saving. Problems emerge when one of the two parts of the existential anaglyph rapidly shrinks like Arctic ice, as factors cross thresholds. Ecological wealth and intergenerational equity areFour at stake. Not enough spending could mean economic stress, social unrest and political conflict. Not enough saving and there will be climate breakdown and ‘bankruptcy’. So where does speculative design start and the gambling and betting end? Behind each fabular frame is a four ratio problem. Each ratio reflects the level of sacrifice and self-restraint a society is willing to accept, against promises of prosperity and freedom. Some values seem to stabilise a frame while others cause collapse. Get the ratios right and we can have it all. Get them wrong and things get more desperate.
Abhay Bhutada, the Managing Director of Poonawalla Fincorp Limited, is an accomplished leader with over 15 years of experience in commercial and retail lending. A Qualified Chartered Accountant, he has been pivotal in leveraging technology to enhance financial services. Starting his career at Bank of India, he later founded TAB Capital Limited and co-founded Poonawalla Finance Private Limited, emphasizing digital lending. Under his leadership, Poonawalla Fincorp achieved a 'AAA' credit rating, integrating acquisitions and emphasizing corporate governance. Actively involved in industry forums and CSR initiatives, Abhay has been recognized with awards like "Young Entrepreneur of India 2017" and "40 under 40 Most Influential Leader for 2020-21." Personally, he values mindfulness, enjoys gardening, yoga, and sees every day as an opportunity for growth and improvement.
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...Donc Test
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting, 8th Canadian Edition by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Ebook Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Pdf Solution Manual For Financial Accounting 8th Canadian Edition Pdf Download Stuvia Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Financial Accounting 8th Canadian Edition Ebook Download Stuvia Financial Accounting 8th Canadian Edition Pdf Financial Accounting 8th Canadian Edition Pdf Download Stuvia
5 Tips for Creating Standard Financial ReportsEasyReports
Well-crafted financial reports serve as vital tools for decision-making and transparency within an organization. By following the undermentioned tips, you can create standardized financial reports that effectively communicate your company's financial health and performance to stakeholders.
2. About
Henry Schein
Henry Schein, Inc., a FORTUNE 500® company and a member of the NASDAQ-100® Index, is the largest
distributor of healthcare products and services to office-based practitioners in the combined North American
and European markets. The Company has been named “Most Admired” in its industry in FORTUNE’s list
of America’s Most Admired Companies, and number one in social responsibility for four consecutive years.
Henry Schein is recognized for its excellent customer The Company operates through a centralized and
automated distribution network, which provides
service and highly competitive prices. The Company’s
customers in more than 200 countries with a
four business groups—Dental, Medical, International
comprehensive selection of more than 90,000
and Technology—serve more than 550,000 customers
national and Henry Schein private-brand products
worldwide, including:
in stock, as well as more than 100,000 additional
• Approximately 85% of the estimated 136,000
products available as special-order items.
U.S. and Canadian office-based dental
Henry Schein also offers a wide range of innovative
practices, as well as dental laboratories;
value-added practice solutions for healthcare
• Approximately 45% of the estimated 250,000 professionals, such as ARUBA®, the Company’s
U.S. office-based physician practices, electronic catalog and ordering system. Its leading
as well as surgical centers and other practice-management software solutions have a
alternate-care sites; user base of more than 52,000 practices, including
DENTRIX®, Easy Dental®, Oasis® and EXACT® for
• Over 75% of the estimated 27,000 animal
dental practices, MicroMD® for physician practices,
health clinics in the United States;
and AVImark® for animal health clinics.
• Approximately 240,000 office-based dental,
Headquartered in Melville, New York, Henry Schein
medical and animal health clinics outside of
employs more than 12,000 people and has
North America, primarily in Europe, Australia
operations or affiliates in 20 countries.
and New Zealand; and
The Company's net sales reached a record
• Government and other institutions providing $5.9 billion in 2007. For more information, visit the
healthcare services. Henry Schein Web site at www.henryschein.com.
1
3. HENRY SCHEIN
AT A GLANCE:
Financial
Highlights
EARNINGS PER DILUTED SHARE
NET SALES OPERATING INCOME
from Continuing Operations (1)
from Continuing Operations from Continuing Operations (1)
($ in Millions) ($ in Millions)
$6,000 $400 $3.00
$5,920
$386
CAGR 17%* CAGR 17%*
CAGR 17%*
$5,000 $2.58
$5,048
$300
$304
$4,526
$4,000 $2.00
$2.03
$262
$3,795
$1.70
$3,000 $217
$200
$3,181 $205
$1.44 $1.39
$179
$2,676
$1.19
$2,000 $1.00
$100
$1,000
$0 $0 $0.00
2002 2003 2004 2005 2006 2007 2002 2003 2004 2005 2006 2007 2002 2003 2004 2005 2006 2007
*Compound Annual Growth Rate
MARKET SIZE
OPERATING CASH FLOW
vs. MARKET SHARE
AND CAPITAL EXPENDITURES
($ in Billions)
($ in Millions) NOTES:
$300 Operating Income and Earnings Per Diluted Share
Serving a Larger Portion of a Growing Market**
from Continuing Operations have been adjusted to
$270 exclude certain one-time items. Refer to Non-GAAP
$250 $255 Disclosures on page 9. Additionally, refer to our
$235 Share: 23%
Share: 6% annual consolidated financial statements for a
$200 complete presentation of our Consolidated
Statements of Cash Flows.
$183
Size: $25.5
Size: $10.0
$150
(1) During 2004, we recorded a non-recurring
$129 $13.2 million pre-tax ($8.4 million post-tax)
$123
$100 charge related to the Fluvirin® contract with
Chiron Corporation. The effect that this charge
$67 1995 2007
$57
$51
$48 had on earnings per diluted share from
$50 $39 $38
continuing operations for the year ended
**Market is defined as the distribution of healthcare products December 25, 2004 was ($0.10). Excluding this
$0
and services primarily to office-based practitioners in charge, our earnings per diluted share from
2002 2003 2004 2005 2006 2007
the combined North American and European markets. continuing operations for 2004 was $1.39.
2
4. Henry Schein At A Glance
DENTAL MEDICAL INTERNATIONAL TECHNOLOGY AND
VALUE-ADDED SERVICES
I 2007 net sales: $1.77 billion
I 2007 net sales: $1.56 billion
I 2007 net sales: $2.46 billion
(including Animal Health)
I 2007 net sales: $132 million
I % of total Company sales: 30%
I % of Company sales: 42%
I % of Company sales: 26%
I % of total Company sales: 2%
(including Animal Health)
I Includes Henry Schein Dental, I Has approximately 17% of the
I Doing business as Henry Schein Practice
I Serves approximately 45% of the
Henry Schein Canada and estimated $10.5 billion combined
Solutions for dental and Henry Schein
estimated 250,000 U.S. office-based
Zahn Dental Laboratory dental, medical and animal health
physician practices, as well as surgical Medical Systems for medical
market in the European countries in
centers and alternate-care sites
I Serves approximately 85% of the
I Practice management and electronic
which we operate
I Has approximately 17% of the
estimated 136,000 U.S. and Canadian
medical records systems user base
estimated $9 billion U.S. distribution
office-based dental practices, I Serves approximately 240,000 of more than 52,000 dental, medical and
market (including Animal Health)
as well as dental laboratories office-based dental, medical and animal health clinics
I Offers approximately 37,000 products in animal health clinics through
I Has approximately 40% of the I Key products include: DENTRIX®,
stock and many more as special-order items operations or affiliates in 18
estimated $6 billion U.S. and Easy Dental®, DentalVision®, Oasis®, and
I Leading supplier of vaccines countries outside of North America:
Canadian distribution market EXACT® for dental practices; MicroMD®
(influenza, tetanus/diphtheria toxoid, Australia, Austria, Belgium,
for physician practices; LabNet® for dental
pneumonococcal and many others),
I Offers approximately 44,000 the Czech Republic, France,
injectables and other pharmaceuticals laboratories; and AVImark® for animal
Germany, Iceland, Ireland, Israel,
products in stock and many
to physicians and alternate-care sites health clinics
Italy, Luxembourg, the Netherlands,
more as special-order items
I Purchase plans for the American
I Value-added services include: repair services
New Zealand, Portugal, Spain,
I Key product exclusives/semi- Medical Association, the American
Switzerland, the United Arab through ProRepair® and COMPLETEcare;
Society of Plastic Surgeons, the American
exclusives: Camlog™ dental implant
Emirates, the United Kingdom office design services; continuing education
Academy of Dermatology, and the
system; Colgate® Oral Care Products;
for healthcare professionals; electronic health
American Academy of Ophthalmology
I Schein Direct provides direct air
DEXIS® digital radiography products;
claims processing (41 million claims
i-CAT™ 3-D Imaging Systems; package delivery service to
processed in 2007); Office Automation
ANIMAL HEALTH
BIOLASE® dental laser systems; practitioners in more than 200
Technology Solutions; 24/7 ordering capability
Milestone Single Tooth Anesthesia™ countries around the world
I Serves over 75% of the estimated through the ARUBA® Web-based electronic
system; KaVo; Noritake dental
27,000 U.S. animal health clinics catalog; Financial Services such as
I Key 2007 acquisition: W&J Dunlop
materials; Pelton & Crane;
equipment leasing and financing, patient
I Offers approximately 23,000 products in Ltd. (U.K., animal health)
BruxGuard™; Pentron® Laboratory
financing, electronic credit card processing
stock and many more as special-order items
Products; and ShadeVision™
and credit facilities; and the Privileges™
I Important new product introductions in
customer loyalty program
2007: Bayer’s Advantage Multi and
ProFender products; Pfizer’s Clavamox;
I Key 2007 acquisition: Software of
Summit Vet Pharm’s Vectra 3D;
Excellence International Ltd. (U.K., Australia,
and Fort Dodge’s Promeris for
New Zealand, dental software)
Dogs and Cats
3
5. To Our
Stockholders
In 2007 our 75th year of operations, we celebrated our commitment to the five constituencies that have led
,
to this important business milestone and our ongoing success—our investors, customers, Team Schein,
supplier partners and society. This steadfast commitment helped make 2007 the most successful year in
our Company’s history.
Record Results and Innovation Growth
Our commitment to our investors was seen in the record Our Company added important new resources to better serve
financial results we posted for the year. Our net sales for our customers and expand Team Schein, our greatest asset,
2007 reached a record $5.9 billion, an increase of 17.3% to more than 12,000 members. We acquired the full-service
over the prior year. This increase includes 14.3% local and special markets business of Becker-Parkin Dental Supply,
currency growth (7.3% internally generated and 7.0% from increasing our dental penetration in several important U.S.
acquisitions, net of divestiture) and 3.0% related to foreign markets. W&J Dunlop Ltd., a leading supplier of animal
currency exchange. Income from continuing operations health products and services to animal health clinics in
for 2007 was $235 million, or $2.58 per diluted share, an the United Kingdom, joined the Henry Schein family of
increase of 28.6% and 27.1%, respectively, compared with companies. We also acquired Software of Excellence
2006. Each of our four business groups posted double-digit International Ltd., a New Zealand-based supplier of
sales gains for the year with net sales of $2.46 billion for dental practice management systems and software in the
Dental, $1.56 billion for Medical (including Animal Health), United Kingdom, Australia and New Zealand.
$1.77 billion for International, and $132 million for Technology.
Strong partnerships with our suppliers resulted in a growing
Additionally we achieved many operational milestones number of important product exclusives and semi-exclusives,
throughout the year, with the continued implementation of which now include the Camlog™ dental implant system;
global corporate programs in human resources, information Colgate® Oral Care Products; DEXIS® digital radiography
technology, inventory management, distribution and other products; i-CAT™ 3-D Imaging Systems; BIOLASE® dental
key areas. We rolled out innovative programs to leverage our laser systems; Milestone Single Tooth Anesthesia™ system;
strengths, and our use of technology was recognized publicly KaVo; Noritake dental materials; Pelton & Crane; Siemens
as Henry Schein ranked 81st in InformationWeek’s Most refurbished ultrasound equipment; BruxGuard™; Pentron®
Innovative Business Technology Companies. Laboratory Products; ShadeVision™; and others.
4
6. A Commitment to Caring
is seen in our use of recycled and environmentally-friendly
Our commitment to society and our reputation for corporate
products in our catalogs, sales flyers, buyers’ guide and
citizenship continues to grow as Henry Schein has been
business cards, as well as this annual report; in our Global
ranked “Most Admired” in our industry in FORTUNE’s list of
Reflections offering of all-natural and recycled products; in
America’s Most Admired Companies, and number one in
the use of energy-efficient products throughout our facilities;
social responsibility for four consecutive years.
{}
and in our new Henry Schein Dental trade show booth,
which incorporates innovations that makes 60% of the
booth’s construction environmentally-friendly.
Through Henry Schein Cares,
We also are committed to using our core competencies
our global social responsibility to enhance healthcare advocacy and education; increase
access to healthcare among underserved populations;
program, we are strengthen community wellness programs and volunteer
activities; and further humanitarian relief and disaster
“Helping Health Happen.
” response. We achieve this goal through the many activities
we support through Henry Schein Cares, our global social
responsibility program that is “helping health happen.”
We recognize that corporate social responsibility means much
more than simply writing a check for charity—it includes a
Our Henry Schein Cares activities throughout the year were
commitment to good corporate governance, to environmental
as diverse as the Team Schein Members who drove their
responsibility and to philanthropic community support.
success. With our supplier partners, we once again
supported thousands of dental team volunteers who provided
In 2007, in the area of corporate governance, EthiSphere™
free treatment to more than 750,000 underserved U.S.
Magazine awarded Henry Schein an “A”—the only one in our
children for the ADA’s fifth annual Give Kids A Smile® day.
industry—for our Code of Conduct, with particular praise for
We expanded our Healthy Children, Healthy Lifestyles
our commitment to stakeholders and the presentation and
program to five U.S. cities. In 10 years, our Back to School
style of information. Our ongoing environmental commitment
5
7. Looking Ahead
2007 will be remembered as a milestone year in our
program has supported more than 7,000 children in nine
Company’s history. We are confident that we can achieve
U.S. states and Canada. And our Holiday Cheer for Children
even more by focusing on the five key priorities detailed in
program again made the holidays a bit brighter for those who
our three-year strategic plan:
are less fortunate.
• Share best practices and services across borders
In addition to these broad initiatives, Team Schein supported
and business functions
countless community-based programs throughout 2007.
• Consistently deliver superior integrated solutions—
We cleaned up parks in New Zealand; Denver, Pennsylvania;
consisting of innovative technology and services—
Jacksonville, Florida; and Indianapolis, Indiana. We built
to meet our customers’ needs in managing their practices
homes in Reno, Nevada, and constructed children’s
• Become trusted consultants and advisors
playgrounds on Long Island, New York. We expanded dental
to our customers
outreach programs in Australia, Germany, the Philippines,
Mongolia, the Ukraine, and across the African continent. We • Develop the strategic Henry Schein global brand
supported an orphanage in Ethiopia and helped the homeless
• Ensure that Team Schein Members continue to be
in New York. We also provided humanitarian relief around
our number one asset
the world through our support of MedShare International,
By addressing these priorities and maintaining our strong
Direct Relief International and other organizations.
commitment to our constituencies, we are confident
Henry Schein uses its core competencies—our distribution that our best years are yet to come. On behalf of our
expertise and our relationships with suppliers and healthcare Board of Directors and my Team Schein colleagues,
professionals—to create public-private partnerships we thank you for your continued support.
that can expand the scale and scope of any program.
Sincerely,
We encourage non-governmental organizations; local,
state and Federal governments; professional associations;
educators; and others in industry to pool their resources
Stanley M. Bergman
with a common goal.
Chairman and Chief Executive Officer
6
8. Board of Directors
Stanley M. Bergman Philip A. Laskawy (1) (3) (4) Standing Row, left to right:
Mark E. Mlotek,
Chairman and Chief Executive Officer Retired Chairman, Ernst & Young LLP
Steven Paladino,
Barry J. Alperin (1) (2) (3) Norman S. Matthews (2) (4)
Paul Brons,
Retired Vice Chairman, Hasbro, Inc. Former President, Federated Louis W. Sullivan,
Department Stores, Inc.
Gerald A. Benjamin Norman S. Matthews,
Mark E. Mlotek Philip A. Laskawy,
Executive Vice President and
Chief Administrative Officer Executive Vice President, Corporate Donald J. Kabat,
Business Development Gerald A. Benjamin
James P. Breslawski
Steven Paladino
President and Chief Operating Officer
Seated Row, left to right:
Executive Vice President and
Paul Brons (4)
Barry J. Alperin,
Chief Financial Officer
Former Member, Board of Management, Margaret A. Hamburg,
Marvin H. Schein
Akzo Nobel, N.V. Stanley M. Bergman,
Founder, Schein Dental Equipment Corp. James P. Breslawski,
Margaret A. Hamburg, M.D. (4)
Marvin H. Schein
Louis W. Sullivan, M.D. (3) (4)
Former Assistant Secretary for
Planning and Evaluation, Former U.S. Secretary of Health
(1) Member Audit Committee
U.S. Department of Health and and Human Services;
Human Services; Former Commissioner Founding Dean, Director and President (2) Member Compensation Committee
of Health for the City of New York Emeritus of the Morehouse School
(3) Member Nominating and
of Medicine
Governance Committee
Donald J. Kabat (1) (2)
Retired Partner, Accenture, Ltd. (4) Member Strategic Advisory
Committee
Executive Officers
Stanley M. Bergman James P. Breslawski Gerald A. Benjamin Leonard A. David James Harding
Chairman and President and Executive Vice President and Senior Vice President and Senior Vice President
Chief Executive Officer Chief Operating Officer Chief Administrative Officer Chief Compliance Officer and Corporate Chief
Technology Officer
Stanley Komaroff Mark E. Mlotek Steven Paladino Michael Racioppi Michael Zack
Senior Advisor Executive Vice President, Executive Vice President and Senior Vice President and President,
Corporate Business Chief Financial Officer Chief Merchandising Officer International Group
Development
7
9. Henry Schein is Committed to its Five Key Constituencies
Supplier Partners
Customers
with whom we will achieve
for whom we seek to be a trusted advisor
mutual business success.
and consultant in building the efficiency and
success of their practices.
Team Schein
for whom we will continue to foster an
entrepreneurial environment marked by
dignity, respect, and opportunities for
personal and professional growth.
Society
Investors
in which we will remain a responsible
for whom we will achieve continued growth
corporate citizen, using our core
and profitability and deliver an excellent
competencies to give back to the
return on investment.
communities in which we operate.
8
10. Non-GAAP Disclosures
The following table sets forth, for the periods indicated, a reconciliation of operating income (loss) and income (loss) from continuing operations adjusted to reflect the effects of discontinued
operations, as reported to adjusted operating income and adjusted income from continuing operations. The diluted earnings (loss) from continuing operations per share and weighted-average
common shares outstanding information reflects a two-for-one stock split effected in the form of a dividend that became effective on February 28, 2005.
Years ended
December 25, December 27, December 28, December 30,
2004 2003 2002 1995
(in thousands, except per share data)
Operating income (loss), as reported $ 191,949 $ 217,432 $ 179,623 $ (1,474)
Adjustments:
Merger, integration, and restructuring credits - - (734) -
Special management compensation costs - - - 20,797
One-time charge related to influenza vaccine contract 13,246 - - -
Adjusted operating income 205,195 217,432 178,889 19,323
Adjusted operating margin 5.4% 6.8% 6.7% 3.1%
Income (loss) from continuing operations, as reported 114,129 128,759 107,271 (10,479)
Adjustments, net of tax:
Merger, integration, and restructuring credits - - (734) -
Special management compensation costs - - - 19,623
Gains on real estate transactions - (454) (890) -
One-time charge related to influenza vaccine contract 8,358 - - -
Adjusted income from continuing operations $ 122,487 $ 128,305 $ 105,647 $ 9,144
Diluted earnings (loss) from continuing operations per share:
As reported $ 1.29 $ 1.45 $ 1.21 $ (0.39)
Adjusted 1.39 1.44 1.19 0.34
Diluted weighted-average common shares outstanding: 88,646 89,099 89,007 26,894
USE OF NON-GAAP MEASURES
The above information includes financial measures that are not calculated and presented in accordance with accounting principles generally accepted in the United States (quot;GAAPquot;).
The above table reconciles operating income (loss), income (loss) from continuing operations and diluted earnings (loss) from continuing operations per share, our most directly
comparable measure calculated and presented in accordance with GAAP, to comparable amounts as adjusted to eliminate the effect of one-time items.
We eliminated the effect of such one-time items to assist in evaluating the underlying operational performance of our business, excluding such one-time items, over the periods
presented. We believe that this presentation is appropriate and facilitates such an evaluation by us, investors and analysts. These measures should be considered supplemental to,
and not a substitute for or superior to, financial measures calculated in accordance with GAAP.
9
11. Henry Schein, Inc.
135 Duryea Road
Melville, New York 11747
U.S.A.
(631) 843-5500
www.henryschein.com